| Time | Topics | Speaker/s | Discussant |
|
09:00
-
09:06
|
Intravitreal Recombinant tpa Before Vitrectomy for Diabetic Tractional Retinal Detachment: A Randomized Controlled Trial
|
Pasha Anvari, MD
|
Ramin Nourinia, MD
|
|
09:09
-
09:15
|
Choroidal Features in Flat Irregular Pigment Epithelial Detachment Associated with Chronic Central Serous Chorioretinopathy: Avascular Versus Vascularized
|
Hamid Riazi Esfahani, MD
|
Khalil Ghasemi Falavarjani, MD
|
|
09:18
-
09:24
|
Choroidal Structure Investigated by Choroidal Vascularity Index in Patients with Inherited Retinal Dystrophies
|
Kia Bayat,
|
Nasser Shoeibi, MD
|
|
09:27
-
09:33
|
The Comparison of Efficacy of Intravitreal Injection of Iranian Made Ranibizumab (Vicentis) with Imported Ranibizumab (Lucentis) in Patients with Diabetic Macular Edema: Double-Blind Noninferiority Clinical Randomized Trial
|
Sayyed amirpooya Alemzadeh, MD
|
Reza Karkhaneh, MD
|
|
09:36
-
09:42
|
Intravitreal Injection of Clonal Bone Marrow-Derived Mesenchymal Stem Cells-Derived Extracellular Vesicles Promotes Retinal Ganglion Cell Survival after Optic Nerve Crush Injury in Rats
|
Elahe sadat Mirsane,
|
Saeed Heidari-keshel, PhD
|
|
09:45
-
09:51
|
Design, Construction and in-Vivo Functional Assessment of SFN0011: A Novel Potent Inhibitor Developed as a Next-Generation Anti-Angiogenic Molecule
|
Hamid LatifiNavid, PhD
|
Alireza Lashay, MD
|
|
09:54
-
10:00
|
Panel Discussion
|
|
|
